Preview |
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
2MB |
Other (Supporting Information)
644kB |
Item Type: | Article |
---|---|
Title: | Small molecule specifically inhibiting microglial nitric oxide release could become a potential treatment for neuroinflammation |
Creators Name: | Jordan, P., Costa, A., Specker, E., Popp, O., Volkamer, A., Piske, R., Obrusnik, T., Kleissle, S., Stuke, K., Rex, A., Neuenschwander, M., von Kries, J.P., Nazare, M., Mertins, P., Kettenmann, H. and Wolf, S.A. |
Abstract: | Microglia are the immune effector cells of the central nervous system (CNS) and react to pathologic events with a complex process including the release of nitric oxide (NO). NO is a free radical, which is toxic for all cells at high concentrations. To target an exaggerated NO release, we tested a library of 16 544 chemical compounds for their effect on lipopolysaccharide (LPS)-induced NO release in cell line and primary neonatal microglia. We identified a compound (C1) which significantly reduced NO release in a dose-dependent manner, with a low IC50 (252 nM) and no toxic side effects in vitro or in vivo. Target finding strategies such as in silico modelling and mass spectroscopy hint towards a direct interaction between C1 and the nitric oxide synthase making C1 a great candidate for specific intra-cellular interaction with the NO producing machinery. |
Keywords: | Cell Line, Lipopolysaccharides, Microglia, Neuroinflammatory Diseases, Nitric Oxide Synthase Type II, Nitric Oxide |
Source: | PLoS ONE |
ISSN: | 1932-6203 |
Publisher: | Public Library of Science |
Volume: | 18 |
Number: | 2 |
Page Range: | e0278325 |
Date: | 6 February 2023 |
Official Publication: | https://doi.org/10.1371/journal.pone.0278325 |
PubMed: | View item in PubMed |
Repository Staff Only: item control page